# A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers

> **NCT02627027** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 26 (actual)

## Conditions studied

- Diabetes Mellitus, Type II

## Interventions

- **DRUG:** Duvie Tab. 0.5mg, Glucodaun OR Tab. 750mg
- **DRUG:** CKD-395 0.25/750mg

## Key facts

- **NCT ID:** NCT02627027
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2016-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02627027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02627027, "A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02627027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*